Sílvia Chaves

18PUBLICATIONS
50CO-AUTHORS
Neurology and neuromuscular diseasesBiologically active moleculesMajor global burdens of diseaseMain group metal chemistryCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 04, 2026
Emerging Roles of Rivastigmine Derivatives Bearing Antioxidant Motifs as Multi-Target Agents for the Management of Neurodegenerative Diseases.

|Aug 28, 2025
Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs.

Inês Dias, Marlène Emmanuel, Paul Vogt

|Mar 27, 2025
Editorial on Special Issue "The Therapy of Alzheimer's Disease: Towards a New Generation of Drugs".

Sílvia Chaves, M Amélia Santos

|Mar 27, 2025
Gadolinium Complex with Tris-Hydroxypyridinone as an Input for New Imaging Probes: Thermodynamic Stability, Molecular Modeling and Biodistribution.

Inês Dias, Lurdes Gano, Sílvia Chaves

|Feb 24, 2024
New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease.

Leo Bon, Angelika Banaś, Inês Dias

|May 13, 2023
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases.

David Vicente-Zurdo, Leonardo Brunetti, Luca Piemontese

Pageof 3

Frequent Collaborators

18 joint publications

Maria Amélia Santos

9 joint publications

Sandra M Cardoso

7 joint publications

Luca Piemontese

5 joint publications

Karam Chand